study question: What type of transferred embryo is associated with a lower rate of ectopic pregnancy? summary answer: The lowest risk of ectopic pregnancy was associated with the transfer of blastocyst, frozen and single embryo com- what is known already: Ectopic pregnancy is a recognized complication following assisted reproductive technology (ART) treatment. It has been estimated that the rate of ectopic pregnancy is doubled in pregnancies following ART treatment compared with spontaneous pregnancies. However, it was not clear whether the excess rate of ectopic pregnancy following ART treatment is related to the underlying demographic factors of women undergoing ART treatment, the number of embryos transferred or the developmental stage of the embryo. main results and the role of chance: The overall rate of ectopic pregnancy was 1.4% for women following ART treatment in Australia and New Zealand. Pregnancies following single embryo transfers had 1.2% ectopic pregnancies, significantly lower than double embryo transfers (1.8%) (P , 0.01). The highest ectopic pregnancy rate was 1.9% for pregnancies from transfers of fresh cleavage embryo, followed by transfers of frozen cleavage embryo (1.7%), transfers of fresh blastocyst (1.3%), and transfers of frozen blastocyst (0.8%). Compared with fresh blastocyst transfer, the likelihood of ectopic pregnancy was 30% higher for fresh cleavage stage embryo transfers (AOR 1.30, 95% CI 1.07 -1.59) and was consistent across subfertility groups. Transfer of frozen blastocyst was associated with a significantly decreased risk of ectopic pregnancy (AOR 0.70, 95% CI 0.54-0.91) compared with transfer of fresh blastocyst.
Introduction
An ectopic pregnancy is a pregnancy where the developing embryo implants outside the endometrial lining of the uterus (McQueen, 2011) . It is a common complication of pregnancy that affects about 1 in 50-80 pregnancies (Farquhar, 2005; Creanga et al., 2011) . The most common place for an ectopic pregnancy is one of the Fallopian tubes, but it can occur in many other sites such as the cervix, ovaries and abdomen. Ectopic pregnancy can be life-threatening due to internal haemorrhage, and remains an important cause of maternal morbidity and mortality worldwide (Sullivan et al., 2004; Farquhar, 2005) . It may also compromise future fertility, which is especially problematic for women undergoing assisted reproductive technology (ART) treatment for their subfertility (Fernandez and Gervaise, 2004) .
The rate of ectopic pregnancy following ART treatment ranges from 2 to 11% among women with tubal related subfertility (Dubuisson et al., 1991; Clayton et al., 2006) , higher than the estimated rate of 1-2% for the general population (Strandell et al., 1999; Farquhar, 2005; Creanga et al., 2011) . It was observed that the subfertility requiring ART treatment is one of the independent risk factors for ectopic pregnancy (Chang and Suh, 2010) . Theoretically it could be expected that ART treatment reduces the risk of ectopic pregnancy since neither fertilization nor embryo transfer involves the Fallopian tubes. Typically one or two embryos are placed directly into the patient's uterus. Therefore the impaired tubal transport mechanisms, which are thought to predispose to ectopic in spontaneous pregnancy, should be bypassed in ART treatment (Jun and Milki, 2004; Revel et al., 2008) .
Among pregnancies following ART treatment, the reproductive health characteristics of women including tubal factor subfertility, endometriosis, previous pelvic inflammatory disease and previous ectopic pregnancy history have been identified as the most prominent risk factors for ectopic pregnancy (Strandell et al., 1999; Chang and Suh, 2010) . The type of ART procedures can also have a significant impact on ectopic pregnancy, such as stage of embryo development (cleavage stage embryo versus blastocysts), the number of embryos transferred, and fresh or frozen/thawed embryo transfer. However, for many procedures the findings are inconsistent in the literature (Bouyer et al., 2003; Jee et al., 2009; Chang and Suh, 2010) . This study aims to add to the body of evidence regarding the relationship between ectopic pregnancy and fresh/frozen embryo at either cleavage or blastocyst stage using Australian and New Zealand population data of pregnancies following autologous ART treatment.
Materials and Methods

Data
Population-based data on 44 102 pregnancies following autologous treatment cycles between January 2009 and December 2011 were obtained from the Australian and New Zealand Assisted Reproduction Technology Database (ANZARD). ART treatment information and clinical outcomes are collected annually from all fertility centres in Australia and New Zealand to monitor the clinical outcomes following ART treatments and to access the effectiveness of ART treatments.
Study factors and outcome measurements
Pregnancies were grouped by following transfers of fresh cleavage embryo, transfers of frozen cleavage embryo, transfers of fresh blastocyst and transfers of frozen blastocyst. The maternal age was based on the completed years of age at time of treatment, and was classified into four groups: ,30, 30-34, 35-39 and over 40 years. The cause of subfertility was classified as female-only if it was the result of tubal disease, endometriosis or subfertility which the treating clinician believed to be due to 'other female factors' such as fibroids or ovulation disorders. Other classifications of cause of subfertility were male factors only, combined male and female factors, and cause of subfertility unknown. Parity was classified as nulliparous, multiparous and not stated.
Pregnancy was defined as a pregnancy that met at least one of the following criteria: known to be ongoing at 20 weeks; evidence by ultrasound of an . Risk of ectopic pregnancy after embryo transfer intrauterine sac with or without a fetal heart; examination of products of conception revealing chorionic villi; or a definite ectopic pregnancy that has been diagnosed laparoscopically or by ultrasound. Ectopic pregnancy within ANZARD is recorded as either ectopic or combined ectopic and uterine pregnancy (heterotopic). The rates of ectopic pregnancy were measured per number of pregnancies.
Statistical analysis
Generalized linear regression using the Poisson distribution was used to estimate the likelihood of ectopic pregnancy following embryo transfer cycles. Potential confounders identified in the literature, including maternal age, parity, cause of subfertility, number of embryos transferred and method of fertilization (IVF/ICSI) were controlled in multivariate analysis. Odds ratios (OR), adjusted odds ratios (AOR) and 95% confidence intervals (CI) were calculated. Findings with a CI not including 1 were considered statistically significant. All statistical analysis was performed using the Statistical Package for the Social Sciences 20.0 software (IBM Corp., Armonk, NY, USA).
Ethical approval
Ethics approval for this study was granted by the Human Research Ethics Committee (HC12373) of the University of New South Wales, Australia.
Results
Between 2009 and 2011, of the 44 102 pregnancies included in the analysis, 620 were reported as ectopic pregnancies, 8 of which were heterotopic pregnancies. The overall rate of ectopic pregnancy was 1.4% for women following ART treatment in Australia and New Zealand (Table I) . The ectopic pregnancy rate was higher among women with tubal factor subfertility (2.2%) or endometriosis (1.7%), compared with couples with male factor-only subfertility (1.4%). The ectopic pregnancy rate for single embryo transfer was 1.2%, which was significantly lower than the 1.8% for double embryo transfer and 2.8% for transfer of three or more embryos (P , 0.01) ( Table I) Including endometriosis and other female factor infertility.
More than two-thirds (67.8%) of women who had fresh cleavage embryos transferred were first time mothers, compared with 57.2% among fresh blastocyst transfer group, 57.4% among frozen cleavage embryos transfer group and 53.3% among frozen blastocyst transfer group. Rates of double and three or more embryo transfer were also highest for fresh cleavage embryo transfer group. Within the fresh cleavage embryo transfer group, 55.5% of transfers were single embryo transfer, 43.3% were double embryo transfers, and 1.2% involved the transfer of three or more embryos. While 78.5% of women with fresh blastocyst transfer and 85.0% of women with frozen blastocyst transfer had single embryo transfer (Table II) .
Overall, the highest ectopic pregnancy rate by the type of embryos transferred was 1.9% for fresh cleavage embryos, followed by 1.7% for frozen cleavage embryos, 1.3% for fresh blastocysts, and 0.8% for frozen blastocysts. The ectopic pregnancy rate following single embryo transfer is lower than that of double embryo transfer for all types of embryos transferred (1.7 versus 2.1% for fresh cleavage embryos, 1.1 versus 1.9% for fresh blastocysts, 0.8 versus 1.1% for frozen blastocysts, respectively), except for frozen cleavage embryos (1.9 versus 1.4%, respectively) (Table III) .
Compared with fresh blastocyst transfer, the likelihood of ectopic pregnancy was 30% higher for fresh cleavage stage embryo transfers (AOR 1.30, 95% CI 1.07 -1.59) and was consistent across subfertility groups. The increased risk of ectopic pregnancy following fresh cleavage embryo transfer compared with fresh blastocyst ranged from 27% in couples with male only or unexplained subfertility to 37% in couples with tubal factor subfertility ( Table IV) . Transfer of frozen blastocyst resulted in significantly decreased risk of ectopic pregnancy (AOR 0.70, 95% CI 0.54 -0.91) compared with transfer of fresh blastocyst (Table IV) .
Discussion
This large population-based study found that the ectopic pregnancy rate following ART treatment was 1.4% in Australia and New Zealand. The ectopic pregnancy rate was lower following single embryo transfer, blastocyst transfer and frozen embryo transfer. These findings suggest that transfer of single frozen/thawed blastocyst was accompanied by a reduced risk of ectopic pregnancy.
The ectopic pregnancy rate in our population-based study (1.4%) was similar to the ectopic pregnancy rate reported for single embryo transfer in the Japanese Registry of Assisted Reproductive Medicine (1.4%) (Ishihara et al., 2011) , and the 1.6% reported in the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry (Society for Assisted Reproductive and American Society for Reproductive, 2007). As ectopic pregnancies in the general population are increasingly being treated medically in outpatient settings, it is difficult to establish current population estimates of ectopic pregnancy incidence rates from hospital admission data (Zane et al., 2002; Farquhar, 2005; Trabert et al., 2011) . However, a trend analysis of incidence of ectopic pregnancy in New South Wales suggested that the incidence is decreasing or stabilizing in Australia. The overall ectopic pregnancy rate decreased from 17.4 per 1000 births in 1990-1991 to 16.2 per 1000 births in 1997-1998 in New South Wales (Boufous et al., 2001) . Similarly, the incidence of ectopic pregnancy following ART treatment in the USA (1.6%) compares favourably with the estimated overall US ectopic pregnancy rate of 2% per pregnancy, which might be associated with the decreased proportion of couples with tubal factor subfertility and increased proportion of couples with male factor subfertility (Society for Assisted Reproductive and American Society for Reproductive, 2007) .
The results of this study showed that blastocyst transfers have a significantly reduced ectopic pregnancy rate compared with cleavage stage embryo transfer. Previous small single-centre studies have reported inconsistent results for comparison between transfer of cleavage embryo and blastocyst regarding ectopic pregnancy rate. An earlier study of 956 clinical pregnancies found that the ectopic pregnancy rate is not reduced following blastocyst transfer compared with cleavage stage embryo transfer (3.9 versus 3.5%, P ¼ 0.8) (Milki and Jun, 2003) . Two US studies (Keegan et al., 2007; Rosman et al., 2009 ) based on the same fertility centre data reported a significant increase in the ectopic pregnancy rate in blastocyst embryo transfer compared with cleavage stage embryo transfer (1.6 versus 0.5%, P ¼ 0.006; and 1.3 versus 0.4%, P ¼ 0.002, respectively). The lower ectopic pregnancy rate than the US national ectopic pregnancy rate seen in these two studies might be associated with the aggressive management of documented tubal disease with salpingectomy in their practice. A more recent retrospective analysis of Japanese Registry of Assisted Reproductive Medicine data has shown similar findings to those reported here, that blastocyst transfer results in a decreased rate of ectopic pregnancy compared with cleavage stage embryo transfer (Ishihara et al., 2011) . Multiple Risk of ectopic pregnancy after embryo transfer hypotheses have been offered to explain the decreased risk of ectopic pregnancy in blastocyst transfer. These include that the larger diameter of the blastocyst would reduce the chances of blastocysts from migrating to the Fallopian tube (Schoolcraft et al., 2001; Chang and Suh, 2010) , the cleavage stage embryos are not prepared temporarily for immediate implantation and could migrate within the reproductive tract before implantation (Milki and Jun, 2003; Ishihara et al., 2011) , and uterine contractility decreases progressively in the luteal phase and reaches a nearly quiescent status at the time of blastocyst transfer which would assist blastocyst implantation and not promote migration of the transferred embryo (Fanchin et al., 2001; Lesny and Killick, 2004) . Compared with fresh blastocyst transfer, the likelihood of ectopic pregnancy was significantly lower for frozen blastocyst transfer. Two earlier studies and one meta-analysis suggested that the ectopic pregnancy rate for fresh embryo transfer cycles was not statistically significant different from that for frozen embryo transfer cycles (Check et al., 2005; Jun and Milki, 2007; Jee et al., 2009 ). However, other recent studies have shown similar findings to those reported here. An analysis of single embryo transfer cycles in Japan found that frozen -thawed transfer has a significantly reduced ectopic pregnancy rate compared with fresh transfer for both cleavage stage embryo and blastocyst (Ishihara et al., 2011) . Similarly, a retrospective cohort study of 8-year data reported that a significantly reduced incidence of ectopic pregnancy was associated with frozen -thawed embryo transfer relative to fresh transfer (Shapiro et al., 2012) . Changes in the uterine environment could be expected to impact ectopic pregnancy rates when frozen embryos are transferred compared with fresh embryo transfer due to the influence of natural versus medicated cycle factors on endometrial receptivity (Jun and Milki, 2007) . The increased risk of ectopic pregnancy following a fresh cycle might indicate the negative effect of ovarian stimulation on endometrial receptivity (Ishihara et al., 2011; Shapiro et al., 2012) . Another mechanism behind this lower ectopic pregnancy rate following a frozen cycle might be the increased uterine contractility in stimulated cycles compared with non-stimulated cycles. Increased uterine contractility in stimulated cycles may favour migration of the embryos into the Fallopian tubes and decrease implantation within the uterine cavity (Jee et al., 2009; Polyzos and Devroey, 2012) .
It has been suggested that the number of embryos transferred in each cycle is an important underlying factor in the aetiology of ectopic pregnancy following ART treatment. As each embryo has independent potential to implant, the risk of ectopic pregnancy could increase with increasing number of embryos transferred (Ishihara et al., 2011) . In the present study, the likelihood of ectopic pregnancy was lowest with single embryo transfer and was highest when three or more embryos transferred. A similar finding was reported by Yanaihara and colleagues, that double embryo transfer resulted in a significantly higher rate of ectopic pregnancy than single embryo transfer (4.4 versus 1.2%, P , 0.05) (Yanaihara et al., 2008) . In addition, a retrospective study in Austria found that the number of embryos transferred increased the probability of an ectopic pregnancy (P ¼ 0.0018) (Weigert et al. (Gelbaya et al., 2010) . This is probably due to the small sample size, in that only five ectopic pregnancies were reported in the three clinical trials included in meta-analysis. A major limitation of this population-based study is the lack of information available on clinic-specific protocols and processes for embryo transfer (i.e. embryo quality, cryopreservation protocol, transfer techniques, etc.). In addition, the ANZARD data lack medical and treatment history of previous ectopic pregnancy. Further data from RCTs comparing differing treatment protocols, for example, single embryo transfer versus double embryo transfer, cleavage versus blastocyst and fresh versus frozen transfers are required to evaluate the underlying mechanisms of ectopic pregnancy following ART treatment reported here. Another potential concern about using the registry data is the accuracy and completeness of ectopic pregnancy reporting in the ART Registry (Clayton et al., 2006) . It is possible that women with an ectopic pregnancy after ART treatment have been diagnosed and treated in outpatient settings and so not reported to the ART clinic. This would lead to an underestimate of ectopic pregnancy rate following ART procedures. However, as discussed, the ectopic pregnancy rate in our population-based study was consistent with the Japanese Registry and US Registry (Society for Assisted Reproductive and American Society for Reproductive, 2007; Ishihara et al., 2011) . The slightly lower ectopic pregnancy rate seen in our study compared with US data could be explained by the high proportion of single embryo transfer, transfer of blastocyst, and transfer of frozen embryos in Australia and New Zealand (Society for Assisted Reproductive and American Society for Reproductive, 2007; Macaldowie et al., 2012; Marsh et al., 2012) . The high proportion of single embryo transfer could also partially explain the low heterotopic pregnancies rate seen in our study.
In clinical settings, the decision to transfer fresh or frozen embryos at cleavage or blastocyst stage should be made to maximize clinical efficacy and to minimize adverse clinical outcomes. Of the data for this study, the efficacy measured by clinical pregnancy rate per transfer cycle was 35.9% for transfers of fresh blastocysts and 29.4% for transfers of frozen blastocysts, higher than the 24.4% for transfers of fresh cleavage embryos and 22.6% for transfers of frozen cleavage embryos. This is supported by a number of review papers which also demonstrated a comparable or higher clinical pregnancy and live delivery rate following transfer of blastocysts than cleavage stage embryos, frozen embryos than fresh embryos, and single embryo transfer than double embryo transfer (Papanikolaou et al., 2008; McLernon et al., 2010; Glujovsky et al., 2012; Roque et al., 2013) . In addition to the higher efficacy following transfer of blastocyst, frozen, and single embryo, our population-based study showed a significantly lower risk of ectopic pregnancy following transfer of a single frozen blastocyst. From a public health perspective, transfer of a single frozen blastocyst should be supported to minimize ectopic pregnancy associated with ART treatment, given that ectopic pregnancy is one of the few life-threatening complications following ART.
